NCT07006454 Comparison of Ventro-Cephalic to Dorso-Caudal Translatoric Glides in Management of Cervicogenic Headache
| NCT ID | NCT07006454 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Cervicogenic Headache |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-07-18 |
| Primary Completion | 2025-06-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-07-18 with a primary completion date of 2025-06-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a randomised control trial and the purpose of this study is to compare ventro-cephalic to dorso-caudal translatoric glides in management of cervicogenic headache.
Eligibility Criteria
Inclusion Criteria: * • Age 18 to 44 years old * Both male and female A- Any headache fulling criterion C. B- Clinical and/or imaging evidence of lesion or disorder in cervical spine or soft tissues of neck that can cause headache. C- Evidence of cause of headache demonstrated by at least 2 of these: 1. headache has developed in temporal relation to the onset of the cervical disorder or lesion. 2. headache has significantly improved or resolved in parallel with improvement in cervical lesion or disorder. 3. cervical range of motion is reduced, and headache is made significantly worse by provocative maneuvers. 4. headache is abolished following diagnostic blocked of cervical structure. D- Not better accounted for by another ICHD-3 diagnosis Exclusion Criteria: * 1- Tension-type headaches and migraine 2- History of Vertigo or Dizziness 3- Already taking manual therapy treatment 4- Prior surgery to the head and neck 5- Trauma
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07006454 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 44 Years, studying Cervicogenic Headache. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07006454 currently recruiting?
Yes, NCT07006454 is actively recruiting participants. Contact the research team at ayeshaaltaf604@gmail.com for enrollment information.
Where is the NCT07006454 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07006454 clinical trial?
NCT07006454 is sponsored by Foundation University Islamabad. The trial plans to enroll 40 participants.